Drugs News and Research

RSS

Researchers compare different types of insulin in treating patients with type 1 or 2 diabetes

Treatment with the insulin degludec compared to glargine U100 for 32 weeks resulted in a reduced rate of hypoglycemic (low blood sugar) episodes among patients with type 1 or 2 diabetes and at least one risk factor for hypoglycemia, according to two studies published by JAMA.

4 Jul 2017

Emory scientists show how same enzyme spurs Alzheimer's and Parkinson's disease

Alzheimer's disease and Parkinson's disease are not the same. They affect different regions of the brain and have distinct genetic and environmental risk factors.

4 Jul 2017

First systematic genomic analysis of patients with T-ALL may aid development of new therapies

A consortium including St. Jude Children's Research Hospital and the Children's Oncology Group has performed an unprecedented genomic sequencing analysis of hundreds of patients with T-lineage acute lymphoblastic leukemia (T-ALL).

4 Jul 2017

Scientists develop new class of pain medication without dangerous side effects

Scientists from Freie Universität Berlin and Charité - Universitätsmedizin Berlin at Campus Benjamin Franklin have developed a new class of pain medication.

4 Jul 2017

Schistosomiasis: the biggest killer you’ve never heard of?

Schistosomiasis is a parasitic disease, sometimes called bilharzia or snail fever. The disease impacts a huge number of people around the world, over 230 million people are infected with one of the schistosome species, the parasitic worms that causes the disease.

4 Jul 2017

New technology can help fight against antimicrobial resistance

Antimicrobial resistance is a growing problem, as some infections that used to be easily cured are now immune to even our most powerful antibiotics.

4 Jul 2017

Commonly prescribed gastric acid drug may increase death risk, study shows

Long-term use of a popular class of drug called proton pump inhibitors (PPIS) has been linked to an increased risk of death in a study published in BMJ Open. The findings add to a growing body of evidence linking the use of PPIs to a range of health problems including kidney damage, bone fracture and dementia.

4 Jul 2017

Study finds increasing incidence of multiple recurring C. difficile infections

Intestinal infection with the bacterium Clostridium difficile is the most frequent healthcare-linked infection in the United States. Each year it afflicts about half a million Americans, causes tens of thousands of deaths, and costs the nation's healthcare system an estimated $5 billion.

4 Jul 2017

Researchers uncover novel mechanism of beta-blockers in preventing progression of heart failure

Beta-blocker drugs serve a key role in the treatment of heart failure, preventing bombardment of the heart by catecholamines - substances like epinephrine and norepinephrine - which overexcite and stress the heart.

4 Jul 2017

Longtime use of heartburn drugs linked to increased risk of death

Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia.

4 Jul 2017

Researchers discover differences between mice and humans in function of insulin-producing beta cells

Research from King's College in London, UK, and Lund University in Sweden could explain why diabetes drugs which have worked in animal experiments are not equally successful in humans.

4 Jul 2017

FDA expands use of cooling cap to minimize chemotherapy-induced hair loss in cancer patients

Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy.

3 Jul 2017

Research reveals biological processes that underlie comorbidity between Alzheimer's disease and cancer

Patients with Alzheimer's disease have a higher risk of developing glioblastoma and a lower risk of lung cancer.

3 Jul 2017

Male fish mutating into females - A toxicological fallout from remnants of human medicines in the ecosystems

According to lead researcher in the field of ecotoxicology, human medicines that end up in the ecosystem are causing mutations in the male fish that mutate them into females. Professor Charles Tyler, fish physiologist and eco-toxicologist from Exeter University, has warned that more and more scientists should work on the exact impact of these drugs and chemicals on nature and marine animals.

3 Jul 2017

New scorpion-milking robot could replace traditional method to extract venom

A new scorpion-milking robot designed to extract venom could replace the traditional manual method. Scorpion venom is used in medical applications such as immunosuppressants, anti-malarial drugs and cancer research, but the extraction process can be potentially life-threatening.

3 Jul 2017

SCT scientists develop Neo-Islet technology for treating insulin-dependent diabetes

The cover of the July 2017 issue of the journal STEM CELLS Translation Medicine showcases the latest advance toward a functional cure of insulin-dependent diabetes.

30 Jun 2017

UTA awards new grants for research projects that focus on cancer, drug testing, and health of youth

The University of Texas at Arlington has awarded three new seed grants for interdisciplinary research projects that propose new ways to treat skin cancer, provide a new technique for more rapid and cost-effective evaluation of chemotherapy drugs, and to develop innovative programs to reduce the mental health risks of homeless youth.

30 Jun 2017

Rhodanine-based compounds show inhibitory activity to prevent aggregation of Tau proteins

The design of tailored peptide-polymer conjugates as drug-specific formulation additives offers access to next generation precision additives that can render problematic small organic drugs water-soluble and improve bioavailability.

30 Jun 2017

EPO blood doping has little effect on amateur cyclists’ road race performance

According to a new study published in The Lancet Haematology, recombinant human erythropoietin (rHuEPO), a performance augmenting drug has little effects on high-intensity laboratory cycling test among well-trained amateur cyclists; yet in the laboratory time trial test and endurance road-race up Mont Ventoux (France), the augmenting effects were typically undetectable.

30 Jun 2017

Differential RNA splicing may play role in prostate cancer disparities in African-American men

A form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer.

30 Jun 2017

Drugs News and Research

Researchers compare different types of insulin in treating patients with type 1 or 2 diabetes

Emory scientists show how same enzyme spurs Alzheimer's and Parkinson's disease

First systematic genomic analysis of patients with T-ALL may aid development of new therapies

Scientists develop new class of pain medication without dangerous side effects

Schistosomiasis: the biggest killer you’ve never heard of?

New technology can help fight against antimicrobial resistance

Commonly prescribed gastric acid drug may increase death risk, study shows

Study finds increasing incidence of multiple recurring C. difficile infections

Researchers uncover novel mechanism of beta-blockers in preventing progression of heart failure

Longtime use of heartburn drugs linked to increased risk of death

Researchers discover differences between mice and humans in function of insulin-producing beta cells

FDA expands use of cooling cap to minimize chemotherapy-induced hair loss in cancer patients

Research reveals biological processes that underlie comorbidity between Alzheimer's disease and cancer

Male fish mutating into females - A toxicological fallout from remnants of human medicines in the ecosystems

New scorpion-milking robot could replace traditional method to extract venom

SCT scientists develop Neo-Islet technology for treating insulin-dependent diabetes

UTA awards new grants for research projects that focus on cancer, drug testing, and health of youth

Rhodanine-based compounds show inhibitory activity to prevent aggregation of Tau proteins

EPO blood doping has little effect on amateur cyclists’ road race performance

Differential RNA splicing may play role in prostate cancer disparities in African-American men

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News